Terms: = Brain cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
34 results:
1. DMC-siercc2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment.
Song M; Wang T; Liu T; Lei T; Teng X; Peng Q; Zhu Q; Chen F; Zhao G; Li K; Qi L
Biomed Pharmacother; 2024 May; 174():116470. PubMed ID: 38565061
[TBL] [Abstract] [Full Text] [Related]
2. Real-World treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
3. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Evaluation of the Management, treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Marcon IG; Valsecchi D; Durso L; Premoli E; Sangiorgi D; Perrone V; Catena L; Degli Esposti L
Adv Ther; 2023 Sep; 40(9):3875-3895. PubMed ID: 37368101
[TBL] [Abstract] [Full Text] [Related]
5. Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma.
Jeon H; Byun J; Kang H; Kim K; Lee E; Kim JH; Hong CK; Song SW; Kim YH; Chong S; Kim JH; Nam SJ; Park JE; Lee S
J Transl Med; 2023 Feb; 21(1):69. PubMed ID: 36732815
[TBL] [Abstract] [Full Text] [Related]
6. A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.
Cheema P; Cho BC; Freitas H; Provencio M; Chen YM; Kim SW; Wu YL; Passaro A; Martin C; Tiseo M; Chang GC; Park K; Solomon B; Burghuber O; Laskin J; Wang Z; Lee SY; Hu Y; Vansteenkiste J; Zhang HL; Hanrahan E; Geldart T; Taylor R; Servidio L; Li J; Marinis F
Future Oncol; 2023 Jan; 19(1):61-75. PubMed ID: 36656302
[TBL] [Abstract] [Full Text] [Related]
7. Resection of posterior fossa tumors in the semi-sitting position in children younger than 4 years of age.
Hermann EJ; Hatipoglu Majernik G; Scheinichen D; Al-Afif S; Heissler HE; Palmaers T; Krauss JK
Childs Nerv Syst; 2023 Jan; 39(1):159-167. PubMed ID: 36348035
[TBL] [Abstract] [Full Text] [Related]
8. Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis.
Liu W; Zhang Q; Zhang T; Li L; Xu C
World J Surg Oncol; 2022 Oct; 20(1):333. PubMed ID: 36192730
[TBL] [Abstract] [Full Text] [Related]
9. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung cancer: Outcome and Safety in the Real World: FLOWER Study.
Lorenzi M; Ferro A; Cecere F; Scattolin D; Del Conte A; Follador A; Pilotto S; Polo V; Santarpia M; Chiari R; Pavan A; Dal Maso A; Da Ros V; Targato G; Vari S; Indraccolo S; Calabrese F; Frega S; Bonanno L; Conte PF; Guarneri V; Pasello G
Oncologist; 2022 Mar; 27(2):87-e115. PubMed ID: 35641222
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract] [Full Text] [Related]
11. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
Agrawal R; Goel V; Anand A; Arora RS
Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
[TBL] [Abstract] [Full Text] [Related]
12. Automated NLP Extraction of Clinical Rationale for treatment Discontinuation in Breast cancer.
Alkaitis MS; Agrawal MN; Riely GJ; Razavi P; Sontag D
JCO Clin Cancer Inform; 2021 May; 5():550-560. PubMed ID: 33989016
[TBL] [Abstract] [Full Text] [Related]
13. Clinical effects of morning and afternoon radiotherapy on high-grade gliomas.
Sapienza LG; Nasra K; Berry R; Danesh L; Little T; Abu-Isa E
Chronobiol Int; 2021 May; 38(5):732-741. PubMed ID: 33557650
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial cancer.
Börcsök J; Sztupinszki Z; Bekele R; Gao SP; Diossy M; Samant AS; Dillon KM; Tisza V; Spisák S; Rusz O; Csabai I; Pappot H; Frazier ZJ; Konieczkowski DJ; Liu D; Vasani N; Rodrigues JA; Solit DB; Hoffman-Censits JH; Plimack ER; Rosenberg JE; Lazaro JB; Taplin ME; Iyer G; Brunak S; Lozsa R; Van Allen EM; Szüts D; Mouw KW; Szallasi Z
Clin Cancer Res; 2021 Apr; 27(7):2011-2022. PubMed ID: 33208343
[TBL] [Abstract] [Full Text] [Related]
15. Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients.
Wick W; Krendyukov A; Junge K; Höger T; Fricke H
J Neurooncol; 2019 Dec; 145(3):531-540. PubMed ID: 31679112
[TBL] [Abstract] [Full Text] [Related]
16. Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE "too young to get cancer?" study.
Dommett RM; Pring H; Cargill J; Beynon P; Cameron A; Cox R; Nechowska A; Wint A; Stevens MCG
BMC Cancer; 2019 Jun; 19(1):616. PubMed ID: 31234813
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Relevance of treatment Failure Patterns in Pediatric High-Grade Glioma: Is There a Role for a Revised Failure Classification System?
Lucas JT; Cooper DA; Hwang S; Tinkle C; Li X; Li Y; Orr B; Merchant TE; Broniscer A
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):450-458. PubMed ID: 28871996
[TBL] [Abstract] [Full Text] [Related]
18. Exploratory analysis of ercc2 DNA methylation in survival among pediatric medulloblastoma patients.
Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
[TBL] [Abstract] [Full Text] [Related]
19. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
Zindler JD; Thomas CR; Hahn SM; Hoffmann AL; Troost EG; Lambin P
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26476075
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract] [Full Text] [Related]
[Next]
